Document is current

Any future updates will be listed below

Sacituzumab tirumotecan improves OS in EGFR TKI-resistant NSCLC

Crossref DOI link: https://doi.org/10.1038/s41571-025-01090-2

Published Online: 2025-10-27

Published Print: 2025-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark